Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug
- 1 January 1999
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 21 (1) , 1-14
- https://doi.org/10.1016/s0192-0561(98)00068-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital WartsAntimicrobial Agents and Chemotherapy, 1998
- Treatment of genital warts with an immune-response modifier (imiquimod)Published by Elsevier ,1998
- Self-administered Topical 5% Imiquimod Cream for External Anogenital WartsArchives of Dermatology, 1998
- Activation of Local Cell-Mediated Immunity in Interferon-Responsive Patients with Human Papillomavirus-Associated LesionsJournal of Interferon & Cytokine Research, 1996
- Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigsVaccine, 1995
- Immunological Events in Regressing Genital WartsAmerican Journal of Clinical Pathology, 1994
- Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion developmentAntiviral Research, 1993
- Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infectionsAntimicrobial Agents and Chemotherapy, 1989
- Efficacy of S26308 against guinea pig cytomegalovirus infectionAntimicrobial Agents and Chemotherapy, 1988
- Influenza: Its Control in Persons and PopulationsThe Journal of Infectious Diseases, 1986